Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG
Cindy Franklin(University of Cologne), Selma Ugurel(Klinikum Bielefeld), Jochen Utikal(German Cancer Research Center), Bastian Schilling(Goethe University Frankfurt), Dirk Debus(Nuremberg Hospital), Edgar Dippel(Klinikum Ludwigshafen), Rudolf Herbst(Helios Klinikum Erfurt), Ralf Gutzmer(University Hospitals of the Ruhr-University of Bochum), Christoffer Gebhardt(Universität Hamburg), Susanne Horn(Vrije Universiteit Brussel), Michael Weichenthal(Christian-Albrechts-Universität zu Kiel), Sebastian Haferkamp(University Hospital Regensburg), Maike Trommer(University of Cologne), Andrea Forschner(University of Tübingen), Claudia Pfoehler(MSH Medical School Hamburg – University of Applied Sciences and Medical University), Gerhard Weyandt(Bayreuth Medical Center), Katharina C. Kähler(Christian-Albrechts-Universität zu Kiel), Dirk Schadendorf(National Center for Tumor Diseases), Friedegund Meier(National Center for Tumor Diseases), Jan‐Malte Placke(Düsseldorf University Hospital), Peter Mohr(Elbe Kliniken Stade-Buxtehude), Georg Lodde(Essen University Hospital), Stephan Grabbe(Goethe University Frankfurt), Fabian Ziller(Vivantes Klinikum), Julia Welzel(University Hospital Augsburg), Elisabeth Livingstone(German Cancer Research Center), Thilo Gambichler(Witten/Herdecke University), Frank Meiß(University of Freiburg), Anca Sindrilaru(Universität Ulm), Marlene Garzarolli, Lisa Zimmer(The University of Sydney), Leonie Bluhm, Jürgen C. Becker(Düsseldorf University Hospital), Jessica C. Hassel(German Cancer Research Center), Gaston Schley(Helios Hospital Schwerin), Carmen Loquai(Johannes Gutenberg University Mainz), Alexander Kreuter(HELIOS St. Elisabeth Klinik Oberhausen), Ulrike Leiter(University of Tübingen), Martin Kaatz(SRH Wald-Klinikum Gera), H. Löffler(University of Mannheim), Lucie Heinzerling(Ludwig-Maximilians-Universität München), Michael Sachse(Klinikum Bremerhaven-Reinkenheide), Dorothée Nashan(Klinikum Dortmund), Jens Ulrich, Carsten Weishaupt(University Hospital Münster), Imke Grimmelmann(Medizinische Hochschule Hannover), Patrick Terheyden(University Hospital Schleswig-Holstein)
Cited by 14
Related Papers
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
|Arthritis & Rheumatism|1990|9.6k
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k